Bioinformatics Business: Technical Status and Market Prospects

Published by: BCC Research

Published: Aug. 1, 2005 - 161 Pages

Table of Contents

INTRODUCTION

GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

CONTRIBUTION OF THE STUDY AND FOR WHOM

SCOPE AND FORMAT

METHODOLOGY

INFORMATION SOURCES

RELATED BCC REPORTS

BCC ON-LINE SERVICES

INTERNET

EXECUTIVE SUMMARY

Summary Table: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, THROUGH 2010 ($ MILLIONS)

Summary Figure: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, 2002-2010 ($ MILLIONS)

OVERVIEW

INDUSTRY DEFINITION

Figure 1 DEFINING BIOINFORMATICS

BIOINFORMATICS IN BIOTECHNOLOGY

CONCEPTS IN THE INDUSTRY

Table 1 WORLDWIDE MARKET FOR BIOINFORMATICS, BY FIELDS OF STUDY, THROUGH 2010 ($ MILLIONS)

GENOMICS

Table 2 WORLDWIDE MARKET FOR GENOMICS, THROUGH 2010 ($ MILLIONS)

PROTEOMICS

Table 3 WORLDWIDE MARKET FOR PROTEOMICS, THROUGH 2010 ($ MILLIONS)

PHARMACOGENOMICS

Table 4 WORLDWIDE MARKET FOR PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)

CHEMINFORMATICS

Table 5 WORLDWIDE MARKET FOR CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)

TECHNOLOGY DEVELOPMENT

HISTORY AND DEVELOPMENT OF INDUSTRY

Figure 2 KEY DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1990-2010

DESCRIPTION OF MAJOR TECHNOLOGIES/APPLICATIONS

BIOINFORMATICS IN DRUG DISCOVERY AND DEVELOPMENT

Table 6 R&D EXPENDITURE ON DRUG DISCOVERY AND DEVELOPMENT, THROUGH 2005 ($ MILLIONS)

LIFE CYCLE OF A DRUG

Table 7 LIFE CYCLE OF A DRUG

FORESEEABLE FUTURE DEVELOPMENTS

EMERGENCE OF NEW TECHNOLOGIES

Image Informatics

Microarray Data Production

In Silico Biology

Protein Folding Computation

Translational Research

Influence of Genomics Versus Proteomics

Metabolomics and the Central Dogma of Molecular Biology

Figure 3 CENTRAL DOGMA OF MOLECULAR BIOLOGY AND BIOINFORMATICS

Future Trends in Bioinformatics

Figure 4 FUTURE TRENDS IN BIOINFORMATICS

MARKETS BY PRODUCT

KEY FUNCTIONS

SUPPLIERS

END-USERS

INDUSTRY DYNAMICS

Figure 5 KEY DYNAMICS IN BIOINFORMATICS INDUSTRY

TOTAL MARKET SIZE

Table 8 WORLDWIDE BIOINFORMATICS MARKET, BY PRODUCT, THROUGH 2010 ($ MILLIONS)

PRODUCT CATEGORIES

CONTENT

Description and Market Size by Database

Figure 6 CATEGORIES OF BIOINFORMATICS DATABASES AND THEIR CONTENT

Table 9 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY DATABASE TYPE, THROUGH 2010 ($ MILLIONS)

Generalized Databases

Table 10 WORLDWIDE GENERALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)

Table 11 SAMPLE LIST OF MAJOR GENERALIZED BIOINFORMATCS DATABASES

Specialized Databases

Table 12 WORLDWIDE SPECIALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)

Table 13 SAMPLE LIST OF MAJOR SPECIALIZED BIOINFORMATICS DATABASES

Description and Market Size by Field of Study

Table 14 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Genomics Based

Table 15 WORLDWIDE BIOINFORMATICS MARKET BY GENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

DNA Sequence

Gene Expression

Proteomics Based

Table 16 WORLDWIDE BIOINFORMATICS MARKET BY PROTEOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

Protein Sequence

Protein Structure

Protein-Protein Interaction

Pharmacogenomics Based

Table 17 WORLDWIDE BIOINFORMATICS MARKET BY PHARMACOGENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

SNP Databases

Cheminformatics Based

Table 18 WORLDWIDE BIOINFORMATICS MARKET BY CHEMINFORMATICS CONTENT, THROUGH 2010 ($ MILLIONS)

Compound Libraries

ANALYSIS SOFTWARE AND SERVICES

Table 19 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Description

Genomics and Proteomics Based

Table 20 WORLDWIDE ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS, THROUGH 2010 ($ MILLIONS)

Table 21 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS BY SOFTWARE CATEGORY, THROUGH 2010 ($ MILLIONS)

Sequence Analysis and Comparison Software

Table 22 LIST OF SAMPLE SEQUENCE ANALYSIS SOFTWARE

BLAST

Transeq

ClustalW

Staden Package

Molecular Imaging/Modeling Programs

RasMol

Structural Analysis/Prediction Software

Table 23 LIST OF SAMPLE STRUCTURE PREDICTION SOFTWARE/PROGRAMS

THREADER

MODELLER

SWISS Pdb Viewer

Pharmacogenomics Based

Table 24 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)

Table 25 LIST OF SAMPLE SNP ANALYSIS SOFTWARE/PROGRAMS

DChipSNP

Genorama Genotyping Software

Cheminformatics Based

Table 26 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)

DEREK for Windows

MACCS

IT INFRASTRUCTURE AND SERVICES

Description

Table 27 WORLDWIDE BIOINFORMATICS IT INFRASTRUCTURE AND SERVICES MARKET BY TYPE OF EQUIPMENT, THROUGH 2010 ($ MILLIONS)

Supercomputers

Clusters

Table 28 COMPONENTS OF A CLUSTER

Multiprocessor Servers

Alternative Classification of IT Infrastructure by Fields of Study

Table 29 WORLDWIDE MARKET FOR IT INFRASTRUCTURE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Growth Drivers

Table 30 KEY GROWTH DRIVERS FOR BIOINFORMATICS PRODUCTS

Shotgun Sequencing

Tandem MS

High Throughput Screening (HTS)

Microarrays

In Silico Modeling

Inhibitors

MARKETS BY END-USER

TOTAL MARKET SIZE

Table 31 WORLDWIDE MARKET FOR BIOINFORMATICS BY END-USER, THROUGH 2010 ($ MILLIONS)

DRUG DISCOVERY AND DEVELOPMENT

APPLICATION DESCRIPTION

Figure 7 VARIOUS PHASES IN DRUG DISCOVERY AND DEVELOPMENT PROCESS

DRUG DISCOVERY PHASE

Target Identification

Target Validation

Lead Identification

Lead Optimization

Table 32 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG-DISCOVERY APPLICATION, THROUGH 2010 ($ MILLIONS)

DRUG DEVELOPMENT PHASE

Preclinical Experiments

Investigational New Drug Application (IND)

Clinical Trials

New Drug Application

NDA Approval

Table 33 SNAPSHOT OF THE DRUG DEVELOPMENT PROCESS

Table 34 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG DEVELOPMENT APPLICATION, THROUGH 2010 ($ MILLIONS)

MARKET DRIVERS FOR BIOINFORMATICS

High Cost of Drug Discovery and Development

Patent Expiration

Table 35 NUMBER OF DRUGS WITH PATENTS EXPIRING, GROUPED BY TREATMENT, 2001-2004

Table 36 PATENT EXPIRATIONS DUE ON BLOCKBUSTER DRUGS, 2004-2008

Need to Reduce Time in Drug Discovery Process

Innovation and Technology in Key Areas of Drug Discovery and Development

Clinical Genomics

Pharmacogenomics

Proteomics

MOLECULAR MEDICINE

APPLICATION DESCRIPTION

Pharmacogenomics and Personalized Medicine

Advantages

Disadvantages

Gene Testing and Preventive Medicine

Advantages

Disadvantages

Gene Therapy

Advantages

Disadvantages

Table 37 WORLDWIDE MARKET FOR BIOINFORMATICS BY MOLECULAR MEDICINE APPLICATION, THROUGH 2010 ($ MILLIONS)

Niche Markets

MICROBIAL GENOME APPLICATIONS

APPLICATION DESCRIPTION

Table 38 SAMPLE APPLICATION PROJECTS OF BIOINFORMATICS TOOLS AND RESOURCES

Radioactive Waste Cleanup

Climate Change

Table 39 MICROORGANISMS INVOLVED IN NITRIFICATION, SEQUENCED USING BIOINFORMATICS TOOLS

Alternative Energy Sources

Antibiotic Resistance

Criteria for Drug Targets

Primary Sequence Comparison Programs

Cluster Analysis

Structural Genomics

Forensic Analysis of Microbes

Evolutionary Studies

AGRICULTURAL APPLICATIONS

APPLICATION DESCRIPTION

Table 40 LIST OF SAMPLE PLANT GENOME DATABASES

COMPARATIVE STUDIES

MARKETS BY REGION

MARKET SIZE

Table 41 BIOINFORMATICS MARKET BY REGION, THROUGH 2010 ($ MILLIONS)

UNITED STATES

Table 42 BIOINFORMATICS MARKET IN THE U.S., THROUGH 2010 ($ MILLIONS)

Table 43 DEPARTMENT OF ENERGY FUNDING FOR THE MICROBIAL GENOME PROJECT, 1997-2004 ($ MILLIONS)

EUROPE

Table 44 BIOINFORMATICS MARKET IN EUROPE, THROUGH 2010 ($ MILLIONS)

ASIA PACIFIC

Table 45 BIOINFORMATICS MARKET IN ASIA PACIFIC, THROUGH 2010 ($ MILLIONS)

Japan

Table 46 BIOINFORMATICS MARKET IN JAPAN, THROUGH 2010 ($ MILLIONS)

India

Australia

Singapore

South Korea

TECHNOLOGY OVERVIEW

TECHNOLOGY AND TOOLS

SOFTWARE

Table 47 MAJOR SOFTWARE LANGUAGES USED IN BIOINFORMATICS SOFTWARE AND THEIR APPLICATION AREAS

MySQL

CORBA Clients

CVS

PHP

BioPerl

BioJava

BioPython

XML

MODES OF DATA INTEGRATION

Table 48 MODES OF DATA INTEGRATION EMPLOYED IN BIOINFORMATICS BUSINESSES

APPLICATION SERVICE PROVIDER

Advantages

Disadvantages

Key Drivers

DATA PIPELINING

Advantages

Disadvantages

DATA WAREHOUSING

Figure 8 DATA WAREHOUSING APPROACH IN BIOINFORMATICS BUSINESSES

Advantages

KEY DEVELOPMENTS

Table 49 KEY HISTORICAL DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1965-2000

PATENT OVERVIEW

PATENT TYPES

ANALYSIS OF PATENTS BY FIELD OF STUDY

Table 50 BIOINFORMATICS PATENTS BY FIELD OF STUDY IN 2003 AND 2004

Genomics Patents

Figure 9 GENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Proteomics Patents

Figure 10 PROTEOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Pharmacogenomics Patents

Figure 11 PHARMACOGENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Cheminformatics Patents

Figure 12 CHEMINFORMATICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

ANALYSIS OF PATENTS BY MAJOR FILERS

Genomics Patents

Figure 13 COMPARISON OF MAJOR FILERS OF GENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Proteomics Patents

Figure 14 COMPARISON OF MAJOR FILERS OF PROTEOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Pharmacogenomics Patents

Figure 15 COMPARISON OF MAJOR FILERS OF PHARMACOGENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Cheminformatics Patents

Figure 16 COMPARISON OF MAJOR FILERS OF CHEMINFORMATICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

ANALYSIS OF PATENTS BY REGION

Table 51 BIOINFORMATICS PATENTS BY REGION, 2003 AND 2004

Figure 17 BIOINFORMATICS PATENTS BY REGION, 2003-2004 (%)

Genomics Patents

Figure 18 GENOMICS PATENTS BY REGION, 2003-2004 (%)

Proteomics Patents

Figure 19 PROTEOMICS PATENTS BY REGION, 2003-2004 (%)

Pharmacogenomics Patents

Figure 20 PHARMACOGENOMICS PATENTS BY REGION, 2003-2004 (%)

Cheminformatics Patents

Figure 21 CHEMINFORMATICS PATENTS BY REGION, 2003-2004 (%)

ABSTRACTS OF RELEVANT PATENTS BY FIELD OF STUDY

GENOMICS

Synthetic Tag Genes

Complexity Management of Genomic DNA by Locus Specific Amplication

Method for Analyzing a Nucleic Acid

PROTEOMICS

Proteomic Analysis

Methods of Obtaining Isoform Specific Expression in Mammalian Cells

PHARMACOGENOMICS

Human Polypeptides Encoded by Polynucleotides and Methods of Their Use

CHEMINFORMATICS

Method and System for Extracting Data From Surface Array Deposited Features

Molecular Nephrotoxicology Modeling

System and Method for Chemical Process Scale-Up and Preliminary Design and Analysis

Methods and Systems for Annotating Biomolecular Sequences

INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS

INDUSTRY OVERVIEW

INDUSTRY GROWTH CURVE

Figure 22 BIOINFORMATICS INDUSTRY GROWTH CURVE

PRODUCT SEGMENTS

REGIONAL MARKETS

BIOINFORMATICS ANALYSTS

Figure 23 SKILL SET REQUIREMENTS FOR BIOINFORMATICS ANALYSTS

DRIVERS FOR THE INDUSTRY

Need to Analyze Biological Data

Need for Enhanced Automation in Drug Discovery and Development

INDUSTRY CHALLENGES

Software Standardization and Data Integration

High-Performance Computing

Figure 24 DATA ANALYSIS AS A CHALLENGE FOR BIOINFORMATICS RESEARCHERS

Lack of Skill-sets

Ethical and Social Issues

Figure 25 BIOINFORMATICS INDUSTRY-VALUE CHAIN

APPLICATION SOFTWARE FROM INDEPENDENT SOFTWARE PROVIDERS (ISPs)

IT Infrastructure

End Users

Pharmaceutical Companies

Biotechnology Companies

Academic Institutions and Research Groups

MODELS

Application Service Providers Model

Software Licenses and Maintenance Fees Model

Research Collaboration Model

Figure 26 COMPARISON OF THE COST AND VALUE ADDED BY DIFFERENT BUSINESS MODELS EMPLOYED IN BIOINFORMATICS BUSINESSES

PRESENT AND FUTURE TRENDS IN THE BIOINFORMATICS INDUSTRY

OUTSOURCING TRENDS IN INDUSTRY

INDUSTRY STRUCTURE

THREATS OF NEW ENTRANTS

BARGAINING POWER OF BUYERS

BARGAINING POWER OF SUPPLIERS

INTER-INDUSTRY COMPETITION

THREATS OF SUBSTITUTES

Figure 27 PORTER'S FIVE FORCES MODEL APPLIED TO THE BIOINFORMATICS INDUSTRY

MERGERS, ACQUISITIONS AND ALLIANCES IN THE BIOINFORMATICS INDUSTRY

Table 52 MAJOR MERGERS, ACQUISITIONS AND ALLIANCES IN THE BIOINFORMATICS INDUSTRY

GOVERNMENT GRANTS

Table 53 R&D SPENDING IN THE NATIONAL INSTITUTE OF HEALTH (NIH)

PROFILES OF COMPANIES

ACCELRYS

AFFYMETRIX

AGILENT TECHNOLOGIES

AMERSHAM BIOSCIENCES

CELERA

COMPUGEN

CURAGEN

GENE LOGIC

GEOSPIZA

IBM LIFE SCIENCES

INCYTE

LION BIOSCIENCE AG

SILICON GRAPHICS

TRIPOS

APPENDICES

LIST OF SIMILARITY SEARCH TOOLS PROVIDED BY THE EUROPEAN BIOINFORMATICS INSTITUTE (EBI)

DNA AND PROTEIN SEARCHES

RIGOROUS PROTEIN SEARCHES

SPECIALIZED DNA SEARCHES

LIST OF SEQUENCE ANALYSIS TOOLS PROVIDED BY EUROPEAN BIOINFORMATICS INSTITUTE (EBI)

LIST OF TABLES

Summary Table: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, THROUGH 2010 ($ MILLIONS)

Table 1 WORLDWIDE MARKET FOR BIOINFORMATICS, BY FIELDS OF STUDY, THROUGH 2010 ($ MILLIONS)

Table 2 WORLDWIDE MARKET FOR GENOMICS, THROUGH 2010 ($ MILLIONS)

Table 3 WORLDWIDE MARKET FOR PROTEOMICS, THROUGH 2010 ($ MILLIONS)

Table 4 WORLDWIDE MARKET FOR PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)

Table 5 WORLDWIDE MARKET FOR CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)

Table 6 R&D EXPENDITURE ON DRUG DISCOVERY AND DEVELOPMENT, THROUGH 2005 ($ MILLIONS)

Table 7 LIFE CYCLE OF A DRUG

Table 8 WORLDWIDE BIOINFORMATICS MARKET, BY PRODUCT, THROUGH 2010 ($ MILLIONS)

Table 9 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY DATABASE TYPE, THROUGH 2010 ($ MILLIONS)

Table 10 WORLDWIDE GENERALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)

Table 11 SAMPLE LIST OF MAJOR GENERALIZED BIOINFORMATCS DATABASES

Table 12 WORLDWIDE SPECIALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)

Table 13 SAMPLE LIST OF MAJOR SPECIALIZED BIOINFORMATICS DATABASES

Table 14 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Table 15 WORLDWIDE BIOINFORMATICS MARKET BY GENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

Table 16 WORLDWIDE BIOINFORMATICS MARKET BY PROTEOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

Table 17 WORLDWIDE BIOINFORMATICS MARKET BY PHARMACOGENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)

Table 18 WORLDWIDE BIOINFORMATICS MARKET BY CHEMINFORMATICS CONTENT, THROUGH 2010 ($ MILLIONS)

Table 19 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Table 20 WORLDWIDE ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS, THROUGH 2010 ($ MILLIONS)

Table 21 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS BY SOFTWARE CATEGORY, THROUGH 2010 ($ MILLIONS)

Table 22 LIST OF SAMPLE SEQUENCE ANALYSIS SOFTWARE

Table 23 LIST OF SAMPLE STRUCTURE PREDICTION SOFTWARE/PROGRAMS

Table 24 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)

Table 25 LIST OF SAMPLE SNP ANALYSIS SOFTWARE/PROGRAMS

Table 26 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)

Table 27 WORLDWIDE BIOINFORMATICS IT INFRASTRUCTURE AND SERVICES MARKET BY TYPE OF EQUIPMENT, THROUGH 2010 ($ MILLIONS)

Table 28 COMPONENTS OF A CLUSTER

Table 29 WORLDWIDE MARKET FOR IT INFRASTRUCTURE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)

Table 30 KEY GROWTH DRIVERS FOR BIOINFORMATICS PRODUCTS

Table 31 WORLDWIDE MARKET FOR BIOINFORMATICS BY END-USER, THROUGH 2010 ($ MILLIONS)

Table 32 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG-DISCOVERY APPLICATION, THROUGH 2010 ($ MILLIONS)

Table 33 SNAPSHOT OF THE DRUG DEVELOPMENT PROCESS

Table 34 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG DEVELOPMENT APPLICATION, THROUGH 2010 ($ MILLIONS)

Table 35 NUMBER OF DRUGS WITH PATENTS EXPIRING, GROUPED BY TREATMENT, 2001-2004

Table 36 PATENT EXPIRATIONS DUE ON BLOCKBUSTER DRUGS, 2004-2008

Table 37 WORLDWIDE MARKET FOR BIOINFORMATICS BY MOLECULAR MEDICINE APPLICATION, THROUGH 2010 ($ MILLIONS)

Table 38 SAMPLE APPLICATION PROJECTS OF BIOINFORMATICS TOOLS AND RESOURCES

Table 39 MICROORGANISMS INVOLVED IN NITRIFICATION, SEQUENCED USING BIOINFORMATICS TOOLS

Table 40 LIST OF SAMPLE PLANT GENOME DATABASES

Table 41 BIOINFORMATICS MARKET BY REGION, THROUGH 2010 ($ MILLIONS)

Table 42 BIOINFORMATICS MARKET IN THE U.S., THROUGH 2010 ($ MILLIONS)

Table 43 DEPARTMENT OF ENERGY FUNDING FOR THE MICROBIAL GENOME PROJECT, 1997-2004 ($ MILLIONS)

Table 44 BIOINFORMATICS MARKET IN EUROPE, THROUGH 2010 ($ MILLIONS)

Table 45 BIOINFORMATICS MARKET IN ASIA PACIFIC, THROUGH 2010 ($ MILLIONS)

Table 46 BIOINFORMATICS MARKET IN JAPAN, THROUGH 2010 ($ MILLIONS)

Table 47 MAJOR SOFTWARE LANGUAGES USED IN BIOINFORMATICS SOFTWARE AND THEIR APPLICATION AREAS

Table 48 MODES OF DATA INTEGRATION EMPLOYED IN BIOINFORMATICS BUSINESSES

Table 49 KEY HISTORICAL DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1965-2000

Table 50 BIOINFORMATICS PATENTS BY FIELD OF STUDY IN 2003 AND 2004

Table 51 BIOINFORMATICS PATENTS BY REGION, 2003 AND 2004

Table 52 MAJOR MERGERS, ACQUISITIONS AND ALLIANCES IN THE BIOINFORMATICS INDUSTRY

Table 53 R&D SPENDING IN THE NATIONAL INSTITUTE OF HEALTH (NIH)

LIST OF FIGURES

Summary Figure: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, 2002-2010 ($ MILLIONS)

Figure 1 DEFINING BIOINFORMATICS

Figure 2 KEY DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1990-2010

Figure 3 CENTRAL DOGMA OF MOLECULAR BIOLOGY AND BIOINFORMATICS

Figure 4 FUTURE TRENDS IN BIOINFORMATICS

Figure 5 KEY DYNAMICS IN BIOINFORMATICS INDUSTRY

Figure 6 CATEGORIES OF BIOINFORMATICS DATABASES AND THEIR CONTENT

Figure 7 VARIOUS PHASES IN DRUG DISCOVERY AND DEVELOPMENT PROCESS

Figure 8 DATA WAREHOUSING APPROACH IN BIOINFORMATICS BUSINESSES

Figure 9 GENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Figure 10 PROTEOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Figure 11 PHARMACOGENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Figure 12 CHEMINFORMATICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)

Figure 13 COMPARISON OF MAJOR FILERS OF GENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Figure 14 COMPARISON OF MAJOR FILERS OF PROTEOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Figure 15 COMPARISON OF MAJOR FILERS OF PHARMACOGENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Figure 16 COMPARISON OF MAJOR FILERS OF CHEMINFORMATICS PATENTS, 2003-2004 (NUMBER OF PATENTS)

Figure 17 BIOINFORMATICS PATENTS BY REGION, 2003-2004 (%)

Figure 18 GENOMICS PATENTS BY REGION, 2003-2004 (%)

Figure 19 PROTEOMICS PATENTS BY REGION, 2003-2004 (%)

Figure 20 PHARMACOGENOMICS PATENTS BY REGION, 2003-2004 (%)

Figure 21 CHEMINFORMATICS PATENTS BY REGION, 2003-2004 (%)

Figure 22 BIOINFORMATICS INDUSTRY GROWTH CURVE

Figure 23 SKILL SET REQUIREMENTS FOR BIOINFORMATICS ANALYSTS

Figure 24 DATA ANALYSIS AS A CHALLENGE FOR BIOINFORMATICS RESEARCHERS

Figure 25 BIOINFORMATICS INDUSTRY-VALUE CHAIN

Figure 26 COMPARISON OF THE COST AND VALUE ADDED BY DIFFERENT BUSINESS MODELS EMPLOYED IN BIOINFORMATICS BUSINESSES

Figure 27 PORTER'S FIVE FORCES MODEL APPLIED TO THE BIOINFORMATICS INDUSTRY

Abstract

• The worldwide value of bioinformatics is expected to increase from $1.02 billion in 2002 to $3.0 billion in 2010, at an average annual growth rate (AAGR) of 15.8%.

• The fastest growing market is expected to be analysis software and services. It is estimated to grow from $444.7 million in 2005 to $1.2 billion in 2010.

• The application of bioinformatics in drug discovery and development is expected to reduce the annual cost of developing a new drug by 33%, and the time for drug discovery by 30%.

• The pharmaceutical companies are expected to increase their R&D expenditures in the future and a major portion of this spending is expected to go into bioinformatics.

INTRODUCTION

Bioinformatics is a set of enabling technologies responsible for the annotation, storage, analysis and search/retrieval of nucleic acid sequence, protein sequence and structural information. This includes integration of the information on the sequences and structures of nucleic acids and proteins into databases such as EMBL, as well as methods to access, search, model and analyze this information.

This BCC study examines the current status of the worldwide bioinformatics industry and assesses its growth potential over a six-year period to 2010. Of particular interest is the value added by bioinformatics in the process of drug discovery and development. Also examined are various technologies and patenting trends in the industry. In addition, market potential for emerging bioinformatics applications such as gene therapy, molecular medicine, etc. is assessed.

Primary focus is on the application of bioinformatics to the process of drug discovery and development, the major user of the technology. Worldwide activity in this sector was considered for this report.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.